Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP478710.RAfF2mr72kwZc6wlNruF-woP1FfTCOWEyYUNSXijGg2uU130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478710.RAfF2mr72kwZc6wlNruF-woP1FfTCOWEyYUNSXijGg2uU130_provenance.
• NP524726.RAlEXGipWEqVVlil1UP6FMe34BjgApCXe1F-ZigiT5pRk130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524726.RAlEXGipWEqVVlil1UP6FMe34BjgApCXe1F-ZigiT5pRk130_provenance.
• NP378107.RAlD4yQi5K86oD0DfUkt__43n6li39-ucjqEGibl6XC04130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378107.RAlD4yQi5K86oD0DfUkt__43n6li39-ucjqEGibl6XC04130_provenance.
• NP495995.RAsJvLSiQ9Nr1i44YqutF19odgJH-McTDqEJmR-UoYF3o130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495995.RAsJvLSiQ9Nr1i44YqutF19odgJH-McTDqEJmR-UoYF3o130_provenance.
• NP594069.RAzZ8QMvrnawrI7FS-e8ydsfb_TuvvamwgrVUOtcDZyBo130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594069.RAzZ8QMvrnawrI7FS-e8ydsfb_TuvvamwgrVUOtcDZyBo130_provenance.
• NP819677.RAu1SQWh7LxrRtlNoyklKuX9GdoqZGOytavy2gdk5eVHA130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819677.RAu1SQWh7LxrRtlNoyklKuX9GdoqZGOytavy2gdk5eVHA130_provenance.
• NP670296.RAZUVcWZsecyxsnfkc4j4VxZqOWqugvAGBlze0sCiPXUM130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670296.RAZUVcWZsecyxsnfkc4j4VxZqOWqugvAGBlze0sCiPXUM130_provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP641882.RAQ2iwLqUhBYFSCnp1i_cM0HOK_QB9JbzEZxNeY2eMGoI130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641882.RAQ2iwLqUhBYFSCnp1i_cM0HOK_QB9JbzEZxNeY2eMGoI130_provenance.
• NP641905.RAZQC8EuyrCSHENUw_JwUOY1rWTT7VIXa5lqco48Ktxi8130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641905.RAZQC8EuyrCSHENUw_JwUOY1rWTT7VIXa5lqco48Ktxi8130_provenance.
• NP642036.RAQat_VpJ4l4L-QgvlaD4W3QsEjyPbHIegGahVoqO-MkM130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642036.RAQat_VpJ4l4L-QgvlaD4W3QsEjyPbHIegGahVoqO-MkM130_provenance.
• NP770211.RA4kZNsCDlMR8GZrUo8kJ1AZT24aXCYmxLainLNXatCSM130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770211.RA4kZNsCDlMR8GZrUo8kJ1AZT24aXCYmxLainLNXatCSM130_provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP829277.RADuEp5New_LUs6kDTcKwcfl6OgD2m_1BNVXxsnUQYNVo130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829277.RADuEp5New_LUs6kDTcKwcfl6OgD2m_1BNVXxsnUQYNVo130_provenance.
• NP829273.RATaBUjz-7-HleIazdoOj1FUJnS9BYb8SZS1vPYEpSvy0130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829273.RATaBUjz-7-HleIazdoOj1FUJnS9BYb8SZS1vPYEpSvy0130_provenance.
• NP829274.RAcMuhxvAmYBqMHQFAJZ7jdBoyEfW2JgP_VGLrun4xv6I130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829274.RAcMuhxvAmYBqMHQFAJZ7jdBoyEfW2JgP_VGLrun4xv6I130_provenance.
• NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
• NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829279.RAfu3p8PXdGnaYYUha-aNBDlhVI781baD_INN4g06fM_8130_provenance.
• NP411870.RAhXcynqLi9tWGMLTxJz_ocNcL82k96Fv1-lF7dpF5J_4130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411870.RAhXcynqLi9tWGMLTxJz_ocNcL82k96Fv1-lF7dpF5J_4130_provenance.
• NP829272.RAliEL5xZG8RCNYHP5RffQEkHbXcvq38KQfQfCEchj8Zw130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829272.RAliEL5xZG8RCNYHP5RffQEkHbXcvq38KQfQfCEchj8Zw130_provenance.
• NP829278.RAko371snq1yeNDBhJ_oqitRo_LGZU-Vut42f309QxL7o130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829278.RAko371snq1yeNDBhJ_oqitRo_LGZU-Vut42f309QxL7o130_provenance.
• NP641746.RAEEjwE98Ydz8vmqYmHzVvX2Tu_j-G4N9pc6dOH0eVdPM130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641746.RAEEjwE98Ydz8vmqYmHzVvX2Tu_j-G4N9pc6dOH0eVdPM130_provenance.
• NP641769.RA-MxaU0FLQg2zJtU-9ZAZ04qOcZVhCph1C5lQzZl5w-8130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641769.RA-MxaU0FLQg2zJtU-9ZAZ04qOcZVhCph1C5lQzZl5w-8130_provenance.
• NP642017.RA-AuJi5w_jHrLc8YQJ7VVihJM1BHAH_Rq6s-4Pwl4wI4130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642017.RA-AuJi5w_jHrLc8YQJ7VVihJM1BHAH_Rq6s-4Pwl4wI4130_provenance.
• NP829271.RAxN341ccaJ4C9hYUaNetto77yK-TVF44b_3G7algPBdw130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829271.RAxN341ccaJ4C9hYUaNetto77yK-TVF44b_3G7algPBdw130_provenance.